WoS SCIE & CAS Academic Rankings
Global Journal Rankings & Directory
Explore academic hierarchies, Clarivate Impact Factors, Web of Science Q1–Q4 quartiles, and CAS divisions.
Showing 51–75 of 232 international scientific journals (Oncology)
| Rank | Journal Name & ISSN | Impact Factor | H-Index | WoS Quartile | Scopus SJR | CAS Division | Self-Citation | Docs/yr | Publisher |
|---|---|---|---|---|---|---|---|---|---|
| #51 | JNCI Cancer Spectrum ISSN: 2515-5091 | 4.8 | 46 | Q2 | 1.72Q1 | CAS Tier 2 | 0% | 104 | Oxford University Press |
| #52 | Neoplasia ISSN: 1522-8002 / 1476-5586 | 4.8 | 151 | Q2 | 2.284Q1 | CAS Tier 2 | 1.6% | 111 | Neoplasia Press |
| #53 | Jco Precision Oncology ISSN: 2473-4284Top Tier | 4.7 | 65 | Q2 | 2.082Q1 | CAS Tier 2 | 1.9% | 161 | LIPPINCOTT WILLIAMS & WILKINS |
| #54 | Medical Oncology ISSN: 1357-0560 / 1559-131X | 4.7 | 98 | Q2 | 0.963Q1 | CAS Tier 3 | 0% | 133 | Springer US |
| #55 | Oncologist ISSN: 1083-7159 / 1549-490XTop Tier | 4.7 | 204 | Q2 | 1.96Q1 | CAS Tier 2 | 4.2% | 278 | AlphaMed Press |
| #56 | Oncology Reports ISSN: 1021-335X / 1791-2431 | 4.7 | 125 | Q2 | 0.887Q2 | CAS Tier 3 | 2.6% | 326 | Spandidos Publications |
| #57 | Oncology Research ISSN: 0965-0407 / 1555-3906 | 4.6 | 79 | Q2 | 1.102Q1 | CAS Tier 2 | 0% | 27 | Cognizant Communication Corporation |
| #58 | Molecular Oncology ISSN: 1574-7891 / 1878-0261Top Tier | 4.5 | 130 | Q2 | 1.738Q1 | CAS Tier 2 | 2% | 239 | John Wiley and Sons Ltd |
| #59 | Cancer Research and Treatment ISSN: 1598-2998 / 2005-9256 | 4.2 | 68 | Q2 | 1.462Q1 | CAS Tier 3 | 4.9% | 119 | Korean Cancer Association |
| #60 | Journal of Gynecologic Oncology ISSN: 2005-0380 / 2005-0399 | 4.2 | 59 | Q1 | 1.256Q1 | CAS Tier 2 | 5.9% | 64 | Korean Society of Gynecologic Oncology and Colposcopy |
| #61 | BMC Cancer ISSN: 1471-2407Top Tier | 4.1 | 180 | Q2 | 1.172Q2 | CAS Tier 2 | 2.9% | 1,321 | BioMed Central |
| #62 | Clinical Lymphoma Myeloma & Leukemia ISSN: 2152-2650 / 2152-2669 | 4.1 | 71 | Q1 | 0.615Q2 | CAS Tier 3 | 3.7% | 230 | Cancer Media Group |
| #63 | Therapeutic Advances in Medical Oncology ISSN: 1758-8340 / 1758-8359 | 4.1 | 80 | Q2 | 1.416Q1 | CAS Tier 2 | 2.3% | 155 | SAGE Publications Inc. |
| #64 | Current Hematologic Malignancy Reports ISSN: 1558-8211 / 1558-822XTop Tier | 4 | 52 | Q2 | 1.191Q1 | CAS Tier 3 | 3.7% | 55 | Springer US |
| #65 | Oncology Reviews ISSN: 1970-5557 / 1970-5565Top Tier | 4 | 35 | Q2 | 1.096Q2 | CAS Tier 3 | 0% | 14 | PAGEPress Publications |
| #66 | Clinical Lung Cancer ISSN: 1525-7304 / 1938-0690 | 3.9 | 83 | Q2 | 1.362Q1 | CAS Tier 3 | 3% | 182 | Elsevier |
| #67 | Journal of Hepatocellular Carcinoma ISSN: 2253-5969 | 3.9 | 17 | Q2 | 0.809Q2 | CAS Tier 3 | 7.1% | 119 | DOVE MEDICAL PRESS LTD |
| #68 | BJC Reports ISSN: 2731-9377 | 3.8 | — | Q2 | — | — | N/A | — | SPRINGERNATURE |
| #69 | Carcinogenesis ISSN: 0143-3334 / 1460-2180 | 3.8 | 230 | Q2 | 1.02Q1 | CAS Tier 3 | 0% | 152 | Oxford University Press |
| #70 | JCO Global Oncology ISSN: 2687-8941 | 3.8 | 50 | Q2 | 1.102Q2 | CAS Tier 3 | 3.1% | 121 | American Society of Clinical Oncology |
| #71 | Breast Cancer ISSN: 1340-6868 / 1880-4233 | 3.7 | 72 | Q1 | 1.036Q1 | CAS Tier 3 | 2.5% | 106 | Springer Japan |
| #72 | Clinical & Experimental Metastasis ISSN: 0262-0898 / 1573-7276 | 3.7 | 114 | Q2 | 1.187Q1 | CAS Tier 3 | 2.4% | 67 | Springer Netherlands |
| #73 | Breast Cancer-Targets and Therapy ISSN: 1179-1314 | 3.6 | 51 | Q2 | 0.992Q2 | CAS Tier 4 | 3% | 54 | Dove Medical Press |
| #74 | Current Oncology ISSN: 1198-0052 / 1718-7729 | 3.6 | 84 | Q2 | 1.132Q2 | CAS Tier 3 | 7.1% | 437 | Multimed Inc. |
| #75 | JCO Clinical Cancer Informatics ISSN: 2473-4276 | 3.6 | 46 | Q2 | 1.174Q1 | CAS Tier 3 | 15.2% | 75 | American Society of Clinical Oncology |